ARROWHEAD PHARMACEUTICALS IN (ARWR)

US04280A1007 - Common Stock

18.96  -0.57 (-2.92%)

After market: 19.02 +0.06 (+0.32%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2024
(2024-9-30)
2023
(2023-9-30)
2022
(2022-9-30)
2021
(2021-9-30)
2020
(2020-9-30)
Revenue
3.55M240.70M243.20M138.30M88.00M
Minority Interest Expense
10.20M4.00M400.00KN/AN/A
Operating Expenses
604.63M445.70M421.70M287.30M181.20M
Research and Development
478.18M332.00M281.20M199.00M123.50M
Selling, General, and Administrative Expenses
107.86M101.30M130.10M80.10M51.70M
Operating Income
-601.08M-205.00M-178.50M-149.00M-93.20M
Interest Income/Expense
-9.63M-3.00M5.00M6.10M9.20M
Other Income/Expense
-1.75M1.50M800.00K2.10M-600.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-612.46M-206.50M-172.70M-140.80M-84.60M
Income Tax
-2.77M2.80M3.80M0.000.00
Net Income
-599.49M-205.30M-176.10M-140.80M-84.60M
EBITDA
-582.49M-192.50M-168.10M-140.70M-87.30M
 
Per Share Data
EPS Diluted Total Ops
-5.00-1.92-1.67-1.36-0.84
Non GAAP EPS
-5.01-1.92-1.68-1.36-0.84
 
Statistics
Profit Margin
-16882.37%-85.29%-72.41%-101.81%-96.14%
Operating Profit Margin
-16927.06%-85.17%-73.40%-107.74%-105.91%

All data in USD

Charts